Lessons Learned for Building Fast & Reliable Analytical Development Strategies from Early Research to Phase I
- Key learnings from accelerating analytical development during the COVID-19 vaccine era
- Establishing fit-for-purpose assays to enable rapid transition from research to clinical manufacturing
- Implementing flexible analytical frameworks to support novel mRNA modalities and vaccine programs